Veru (STU:FMW) Long-Term Debt : €7.97 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Veru Long-Term Debt?

Veru's Long-Term Debt for the quarter that ended in Jun. 2024 was €7.97 Mil.

Veru's quarterly Long-Term Debt declined from Dec. 2023 (€8.15 Mil) to Mar. 2024 (€8.07 Mil) and declined from Mar. 2024 (€8.07 Mil) to Jun. 2024 (€7.97 Mil).

Veru's annual Long-Term Debt increased from Sep. 2021 (€7.99 Mil) to Sep. 2022 (€9.75 Mil) but then declined from Sep. 2022 (€9.75 Mil) to Sep. 2023 (€8.31 Mil).

Veru Long-Term Debt Historical Data

The historical data trend for Veru's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veru Long-Term Debt Chart

Veru Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Long-Term Debt

Get a 7-Day Free Trial

6.11

4.77

7.99

9.75

8.31

Veru Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Long-Term Debt	Get a 7-Day Free Trial															8.56	8.31	8.15	8.07	7.97

Veru (STU:FMW) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Veru Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Veru's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Veru Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veru Inc (STU:FMW) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

VERU:USA FMW:Germany

Address

2916 North Miami Avenue, Suite 1000, Miami, FL, USA, 33127

Website

https://www.verupharma.com

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

Veru Headlines

No Headlines